Trade RMTI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Rockwell Medical, Inc. (RMTI) is trading at US$8.07, up 1.96% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$32.65M. Over the past 52 weeks, RMTI has traded between US$4.89 and US$13.30. On Syfe you can trade RMTI with $0 commission and add it to your watchlist.
| Previous close | US$7.91 |
|---|---|
| Market cap | US$32.65M |
| 52-week range | US$4.89 – US$13.30 |
| Volume | 44.48K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Rockwell Medical, Inc.
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
Year: 1998
Rockwell Medical Regains Compliance With Nasdaq Minimum Bid Price Requirement
Jul 20, 11:38 AM · MT Newswires
Rockwell Medical Board Approves 1-for-10 Reverse Stock Split
Jun 29, 10:58 AM · MT Newswires
Rockwell Medical, Inc. (RMTI) stock is trading at US$8.07, +1.96% from the previous close of US$7.91.
The market cap for Rockwell Medical, Inc. (RMTI) stock is approximately US$32.65M.
The 52-week high for Rockwell Medical, Inc. (RMTI) stock is US$13.30.
The 52-week low for Rockwell Medical, Inc. (RMTI) stock is US$4.89.
Rockwell Medical, Inc. (RMTI) does not currently pay a dividend.
Stay on top of RMTI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
